Select Page

Aurora Health Care Coordinates National Research Study to Improve Brain Clot Removal Outcomes

Contact:           Matt Braun,

(414) 299-1547

matthew.braun@aurora.org

Milwaukee, Wis. – Each year, nearly 130,000 people in the United States die from stroke, many of them from intracerebral hemorrhage.

In an effort to help improve health quality for patients, Aurora Health Care’s Aurora Research Institute has launched a multicenter research study to assess the outcomes of a unique, minimally invasive surgical approach to safely remove clots in study subjects with intracerebral hemorrhage in deep areas of the brain.

Intracerebral hemorrhage is a type of stroke that occurs when a blood vessel in the brain bursts, most often due to high blood pressure. The pressure from the blood leaking inside the brain can damage brains tissue and lead to permanent disability and death.

Aurora Vice President of Neurosciences, Amin Kassam, MD, is leading the study at Aurora St. Luke’s Medical Center in Milwaukee, Wisconsin, which serves as the coordinating site for the study, known as the Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation, or MiSPACE. Up to 12 sites nationwide will participate in the program.

“MiSPACE provides an important opportunity to study the clinical and economic impact of a minimally invasive approach to patients with hemorrhagic stroke,” said Sara Planton, director of Clinical Trials for the Aurora Research Institute. “Under Dr. Kassam’s direction, Aurora St. Luke’s will serve as the national hub and coordinating site for this important, multicenter trial.”

The goal of the study is to assess clinical outcomes in up to 50 study subjects surgically treated for subcortical intracerebral hemorrhage. A systems approach will be used that integrates five core competencies for safe and consistent use at 30- and 90-day increments.

As an additional measure, investigators also will perform an economic analysis, comparing inpatient care costs of patients who undergo the unique surgical approach to those managed with drugs or conventional surgical treatment.

“The problem we have today is that a ‘wait and see’ approach to hemorrhage resolution does not always result in the best outcome for the patient,” Dr. Kassam said. “It is our hope that by using this new, integrated surgical approach of subcortical parafascicular access with early intervention, we will provide a better end-result with less trauma to the patient and improved functional outcomes.”

 

Aurora Health Care is a not-for-profit Wisconsin-area health care provider and a national leader in efforts to improve health care quality. Aurora offers services at sites in more than 90 communities throughout eastern Wisconsin and northern Illinois. Aurora is Wisconsin’s most comprehensive health care provider and the state’s largest private employer. Aurora serves more than 1.2 million patients every year via a comprehensive network of facilities, services and providers, including 15 hospitals, 159 clinics, 70 pharmacies and 30,000 amazing Caregivers. As evidenced by more than 400 active clinical trials, Aurora is dedicated to delivering innovations to provide the best possible care today, and to define the best care for tomorrow. Get helpful health and wellness information via the Aurora MyHealth blog, our Facebook page, our Twitter account and our Pinterest account.

 

# # #

STAY INFORMED ON THE STATE’S MOST PRESSING HEALTHCARE ISSUES AND INITIATIVES.

Subscribe here for a FREE 14 day trial of our daily news roundup.

You have Successfully Subscribed!

Pin It on Pinterest